RxDoctor Payments Data

Wilbur Montana, DO

Hematology & Oncology · Cerritos, CANPI 1457793051

Payments from drug & device makers

$10,616in general payments, 2019–2025

Across 461 payments — averaging $23.03 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Novartis$2K
  • Sanofi$837
  • E.r. Squibb & Sons, L.L.C.$576
  • Incyte Corporation$503
  • Amgen$442
  • Gilead$436
  • plus $6K from 53 others

What the payments were for

  • Food & beverage$8,72282%
  • Education$3283%
  • Other$1,56515%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Novartis40$1,929
Sanofi25$837
E.r. Squibb & Sons, L.L.C.35$576
Incyte Corporation18$503
Amgen19$442
Gilead(2 entities)14$436
AstraZeneca(2 entities)21$400
Johnson & Johnson28$369
Pfizer26$357
GSK17$356
Seagen Inc.17$341
Astellas Pharma US Inc11$298
Genentech USA, Inc.19$294
Bristol Myers Squibb16$253
Sobi, Inc14$243
Daiichi Sankyo Inc.18$226
Exelixis Inc.10$206
Octapharma USA, Inc.2$194
Regeneron Healthcare Solutions, Inc.6$179
Tesaro, Inc.12$179
Takeda Pharmaceuticals U.S.A., Inc.6$136
Teva Pharmaceuticals USA, Inc.7$132
Myriad Genetic Laboratories, Inc.4$120
Pharmacyclics LLC, An Abbvie Company5$105
Eisai Inc.5$103
Karyopharm Therapeutics Inc.4$91
Jazz Pharmaceuticals Inc.5$90
Bayer5$85
Merck4$77
Coherus Oncology, Inc.4$73
Ipsen Biopharmaceuticals, Inc3$66
EMD Serono, Inc.3$62
Blueprint Medicines Corporation2$58
AVEO Pharmaceuticals, Inc.2$54
Lilly USA, LLC3$53
ADC Therapeutics America, Inc.2$52
Kyowa Kirin, Inc.2$51
Servier Pharmaceuticals LLC2$48
Genmab U.S., Inc.2$47
Clovis Oncology, Inc.2$46
AbbVie2$40
Mirati Therapeutics, Inc.2$35
TG Therapeutics, Inc.1$31
Janssen Scientific Affairs, LLC1$29
Pharmaessentia USA Corporation1$29
Sun Pharmaceutical Industries Inc.1$27
Rigel Pharmaceuticals, Inc.1$27
Taiho Oncology, Inc.1$26
Travere Therapeutics, Inc.1$25
Puma Biotechnology, Inc.1$22
Deciphera Pharmaceuticals Inc.1$22
G1 Therapeutics, Inc.1$21
CTI Biopharma Corp.1$20
Morphosys, US Inc.1$20
Apellis Pharmaceuticals, Inc.1$20
Integra Lifesciences Corporation1$18
Agios Pharmaceuticals, Inc.1$17
Epizyme, Inc.1$12
AMAG Pharmaceuticals, Inc.1$11

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$10,616 in reported general payments places this provider in the 50th percentile of 1,363 hematology & oncology providers in California.

See all hematology & oncology providers in California

Medicare billing

Part B allowed, 2024
$49,375
Medicare patients
176
Services billed
584

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Prednisone13$100

Paid to pharmacies, not to this prescriber.

Other hematology & oncology in Cerritos

See the full list for California

Where these figures come from

Is this you, or does something look wrong? →